X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (25) 25
female (18) 18
index medicus (18) 18
malaria (17) 17
male (17) 17
infectious diseases (16) 16
clinical trials (15) 15
medicine, general & internal (12) 12
child (11) 11
adult (10) 10
children (10) 10
studies (10) 10
child, preschool (9) 9
double-blind method (9) 9
gabon (9) 9
infectious disease (9) 9
malaria, falciparum - drug therapy (9) 9
drug therapy (8) 8
health aspects (8) 8
plasmodium falciparum (8) 8
vaccines (8) 8
antimalarials - therapeutic use (7) 7
infant (7) 7
medical research (7) 7
parasitic diseases (7) 7
safety (7) 7
adolescent (6) 6
animals (6) 6
efficacy (6) 6
malaria, falciparum - parasitology (6) 6
middle aged (6) 6
plasmodium falciparum - drug effects (6) 6
treatment outcome (6) 6
adults (5) 5
antimalarials (5) 5
antimalarials - administration & dosage (5) 5
chloroquine (5) 5
drug resistance (5) 5
drug therapy, combination (5) 5
ebola virus (5) 5
infections (5) 5
internal medicine (5) 5
product development (5) 5
vaccination (5) 5
aged (4) 4
dihydroartemisinin-piperaquine (4) 4
drug administration schedule (4) 4
drug combinations (4) 4
immunology (4) 4
malaria, falciparum - blood (4) 4
malaria, falciparum - prevention & control (4) 4
medicine (4) 4
medicine, experimental (4) 4
plasmodium-falciparum (4) 4
prevention (4) 4
resistance (4) 4
young adult (4) 4
analysis (3) 3
antibodies (3) 3
antimalarials - adverse effects (3) 3
artemether-lumefantrine (3) 3
artemisinins - therapeutic use (3) 3
artesunate (3) 3
arthritis (3) 3
combinations (3) 3
dosage and administration (3) 3
double-blind (3) 3
drug dosages (3) 3
ebola virus infections (3) 3
endocrinology (3) 3
epidemiology (3) 3
evaluation (3) 3
fever (3) 3
gastroenterology (3) 3
genotype (3) 3
glycoproteins (3) 3
immunization (3) 3
immunogenicity (3) 3
infection (3) 3
medicine & public health (3) 3
medicine/public health, general (3) 3
parasites (3) 3
patients (3) 3
plasmodium-falciparum malaria (3) 3
pneumology/respiratory system (3) 3
research (3) 3
research article (3) 3
risk factors (3) 3
sulfadoxine-pyrimethamine (3) 3
virus diseases (3) 3
viruses (3) 3
activation (2) 2
africa (2) 2
african children (2) 2
age (2) 2
aminoquinolines - therapeutic use (2) 2
anti-infective agents - administration & dosage (2) 2
antibodies, viral - blood (2) 2
antibody (2) 2
antigens (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2013, Volume 13, Issue 6, pp. 485 - 496
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 12, pp. 1450 - 1458
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 10, pp. 1156 - 1166
Summary Background Safe and effective vaccines against Ebola could prevent or control outbreaks. The safe use of replication-competent vaccines requires a... 
Infectious Disease | INFECTIOUS DISEASES | MARBURG VIRUS | ACTIVATION | DUCK RUBELLA VACCINE | IMMUNE-RESPONSES | PROTECTS NONHUMAN-PRIMATES | VESICULAR STOMATITIS | GLYCOPROTEINS | INFECTION | FEVER | AGE | Hemorrhagic Fever, Ebola - prevention & control | Vasculitis - epidemiology | Arthritis - epidemiology | Humans | Middle Aged | Vasculitis - pathology | Antigens, Viral - genetics | Male | Vaccination - adverse effects | Vaccines, Synthetic - immunology | Ebolavirus - genetics | Antibodies, Viral - blood | Dermatitis - epidemiology | Drug Carriers | Drug-Related Side Effects and Adverse Reactions - pathology | Young Adult | Arthritis - chemically induced | Vaccination - methods | Vaccines, Synthetic - adverse effects | Vesiculovirus - genetics | Adult | Ebola Vaccines - immunology | Female | Vasculitis - chemically induced | Placebos - administration & dosage | Double-Blind Method | Arthritis - pathology | Ebola Vaccines - administration & dosage | Ebola Vaccines - adverse effects | Switzerland | Drug-Related Side Effects and Adverse Reactions - epidemiology | Dermatitis - pathology | Adolescent | Aged | Vaccines, Synthetic - administration & dosage | Ebola virus | Hospitals | Clinical trials | Product development | Cross infection | Vaccines | Nosocomial infections | Health aspects | Epidemics | Disease | Arthritis | Dermatitis | Ankle | Wrist | Consortia | Pain | Adenoviruses | Fingers & toes | Skin | Public health
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9700, pp. 1533 - 1542
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2013, Volume 13, Issue 8, pp. 680 - 689
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 12, pp. 1409 - 1419
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 6, pp. 636 - 644
Summary Background A drug for causal (ie, pre-erythrocytic) prophylaxis of Plasmodium falciparum malaria with prolonged activity would substantially advance... 
Infectious Disease | DIRECT VENOUS INOCULATION | INFECTIOUS DISEASES | SPOROZOITES | CANDIDATE | TRAVELERS | GEOSENTINEL SURVEILLANCE NETWORK | Malaria, Falciparum - drug therapy | Triazoles - administration & dosage | Double-Blind Method | Parasitemia - immunology | Pyrimidines - administration & dosage | Chemoprevention | Humans | Middle Aged | Male | Antimalarials - therapeutic use | Plasmodium falciparum - immunology | Sporozoites - immunology | Malaria, Falciparum - parasitology | Administration, Intravenous | Antimalarials - administration & dosage | Pyrimidines - therapeutic use | Adolescent | Malaria, Falciparum - immunology | Parasitemia - parasitology | Adult | Female | Volunteers | Triazoles - therapeutic use | Plasmodium falciparum | Control | Malaria | Health aspects | Infection control | Analysis | Liver | Drugs | Animal models | Dehydrogenases | Plasmodia | Arches | Clinical trials | Risk | Population studies | Infections | Biosynthesis | Parasites | Vaccines | Drug development | Dosage | Blood | Prevention | Contraceptives | Pyrimidines | Databases | Developmental stages | Contraceptives (oral) | Cryopreservation | Children | Safety | Drug dosages | Public health | Receiving | Effectiveness | Chemoprotection | Atovaquone | Pharmacology | Bioavailability | Disease control | Statistics | Thrombosis | Studies | Inhibitors | Surveillance | Human beings | Computation | Antimalarial agents | Documents | Air transportation | Added value | Dihydroorotate dehydrogenase
Journal Article